These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 38291517)

  • 1. Research progress of N1-methyladenosine RNA modification in cancer.
    Liu Y; Zhang S; Gao X; Ru Y; Gu X; Hu X
    Cell Commun Signal; 2024 Jan; 22(1):79. PubMed ID: 38291517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N
    Li J; Zhang H; Wang H
    Comput Struct Biotechnol J; 2022; 20():6578-6585. PubMed ID: 36467585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone lactylation-boosted ALKBH3 potentiates tumor progression and diminished promyelocytic leukemia protein nuclear condensates by m1A demethylation of SP100A.
    Gu X; Zhuang A; Yu J; Yang L; Ge S; Ruan J; Jia R; Fan X; Chai P
    Nucleic Acids Res; 2024 Mar; 52(5):2273-2289. PubMed ID: 38118002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Molecular Basis of Human ALKBH3 Mediated RNA N
    Zhang L; Duan HC; Paduch M; Hu J; Zhang C; Mu Y; Lin H; He C; Kossiakoff AA; Jia G; Zhang L
    Angew Chem Int Ed Engl; 2024 Feb; 63(7):e202313900. PubMed ID: 38158383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic characteristics and prognostic implications of m1A regulators in pancreatic cancer.
    Zheng Q; Yu X; Zhang Q; He Y; Guo W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. m6A readers, writers, erasers, and the m6A epitranscriptome in breast cancer.
    Petri BJ; Klinge CM
    J Mol Endocrinol; 2023 Feb; 70(2):. PubMed ID: 36367225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
    He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
    J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of m
    Singh S; Gupta S; Abhishek R; Sachan M
    Funct Integr Genomics; 2024 Oct; 24(6):193. PubMed ID: 39438339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic transcriptomic m
    Yang Y; Hsu PJ; Chen YS; Yang YG
    Cell Res; 2018 Jun; 28(6):616-624. PubMed ID: 29789545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of the m1A writer TRMT6/TRMT61A reduces proliferation and resistance against cellular stress in bladder cancer.
    Monshaugen I; Luna L; Rhodes J; Kristiansen FIS; Lång A; Bøe SO; Dutta A; Su Z; Klungland A; Ougland R
    Front Oncol; 2023; 13():1334112. PubMed ID: 38304034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA m6A methylation regulators in sepsis.
    Zhu L; Zhang H; Zhang X; Xia L
    Mol Cell Biochem; 2024 Sep; 479(9):2165-2180. PubMed ID: 37659034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO.
    Zuidhof HR; Calkhoven CF
    Cancer Res; 2022 Jun; 82(12):2201-2212. PubMed ID: 35303057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The potential role of RNA N6-methyladenosine in Cancer progression.
    Wang T; Kong S; Tao M; Ju S
    Mol Cancer; 2020 May; 19(1):88. PubMed ID: 32398132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predicting response of immunotherapy and targeted therapy and prognosis characteristics for renal clear cell carcinoma based on m1A methylation regulators.
    Li L; Tan H; Zhou J; Hu F
    Sci Rep; 2023 Aug; 13(1):12645. PubMed ID: 37542141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Research advances of N6-methyladenosine in diagnosis and therapy of pancreatic cancer.
    Chen S; Ren H; Zhang X; Chang L; Wang Z; Wu H; Zhang J; Ren J; Zhou L
    J Clin Lab Anal; 2022 Sep; 36(9):e24611. PubMed ID: 35837987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of m6A modification in the biological functions and diseases.
    Jiang X; Liu B; Nie Z; Duan L; Xiong Q; Jin Z; Yang C; Chen Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):74. PubMed ID: 33611339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Writers, readers, and erasers RNA modifications and drug resistance in cancer.
    Chen D; Gu X; Nurzat Y; Xu L; Li X; Wu L; Jiao H; Gao P; Zhu X; Yan D; Li S; Xue C
    Mol Cancer; 2024 Aug; 23(1):178. PubMed ID: 39215288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Reader-Based Assay for m
    Wiedmer L; Eberle SA; Bedi RK; Śledź P; Caflisch A
    Anal Chem; 2019 Feb; 91(4):3078-3084. PubMed ID: 30715855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ALKBH1-mediated m
    Chen W; Wang H; Mi S; Shao L; Xu Z; Xue M
    Mol Oncol; 2023 Feb; 17(2):344-364. PubMed ID: 36550779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Demethylase Genes, FTO and ALKBH1, Is Associated with Prognosis of Gastric Cancer.
    Li Y; Zheng D; Wang F; Xu Y; Yu H; Zhang H
    Dig Dis Sci; 2019 Jun; 64(6):1503-1513. PubMed ID: 30637548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.